Korea Investment Partners — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
INOVIO is a biotechnology company developing DNA medicines to treat or prevent disease, with a clinical pipeline focused on HPV-related diseases, oncology, and infectious disease.
BiotechHealthtechPlymouth Meeting, US
J. Jospeh Kim(Executive Officer, Director)Peter Kies(Chief Financial Officer)Jacqueline Shea(President & Chief Executive Officer)inLaurent Humeau(Chief Scientific Officer)Michael Sumner(Chief Medical Officer & Head of Development)Steve Egge(Chief Commercial Officer)in
Gushcloud provides creator management and licensing services, alongside content publishing, capital financing, and AI-powered monetization tools for creators and brands in the entertainment industry.
AI & Machine LearningCreator EconomyMarketing TechMedia & Entertainment
Althea Limin
Co-investorsKejora CapitalLiquidity CapitalLotte VenturesWavemaker Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.